Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Transcept's Intermezzo: A Blockbuster In The Making
Seeking Alpha
Tuesday, January 3, 2012 - 10:18am
tags:
Intermezzo, Transcept, insomnia
Departure of ’String of Pearls’ Strategist Leaves Gap at Bristol-Myers
Bloomberg
Tuesday, January 3, 2012 - 10:15am
tags:
Bristol-Myers Squibb, Teva Pharmaceuticals, Jeremy Levin
The War Against Alzheimer's Requires Thinking Small
Investopedia
Tuesday, January 3, 2012 - 10:14am
tags:
Alzheimer's disease, AstraZeneca, Astex, Elan, Intellect Neurosciences, Pfizer
2012 Preview: Aeterna Zentaris
Motley Fool
Monday, January 2, 2012 - 5:56pm
tags:
Aeterna Zentaris
Biotech’s Glass Half Full for 2012
Life Sci VC
Monday, January 2, 2012 - 3:42pm
tags:
biotech, funding, M&A
Veloxis, Athena ink deal for pill combining 2 heart disease drugs
Fierce Drug Delivery
Monday, January 2, 2012 - 3:10pm
tags:
Veloxis, Athena, dyslipidemia, AtorFen
Apricus Misses Promised Drug Launch Target
TheStreet.com
Monday, January 2, 2012 - 3:01pm
tags:
Apricus Biosciences, Vitaros, erectile dysfunction
Salix Pharma: Still Has Room To Run
Seeking Alpha
Monday, January 2, 2012 - 1:54pm
tags:
Salix
Bristol’s Acquisition Plans Won’t Change With Loss of Levin to Teva
Bloomberg
Monday, January 2, 2012 - 1:52pm
tags:
Bristol-Myers Squibb, Teva Pharmaceuticals, Jeremy Levin, M&A
Indian pharma companies obtains 144 ANDA approvals from US FDA in 2011
Pharmabiz.com, India
Monday, January 2, 2012 - 1:06pm
tags:
FDA, India, drug approvals
Seattle Genetics: Innovative Biotech, Speculative Stock
Seeking Alpha
Monday, January 2, 2012 - 11:24am
tags:
Seattle Genetics, antibody-drug conjugate
ViroPharma Is Poised For Gain
Seeking Alpha
Monday, January 2, 2012 - 11:10am
tags:
ViroPharma
2011 Review: Cell Therapeutics
Motley Fool
Monday, January 2, 2012 - 11:08am
tags:
Cell Therapeutics
Top Undervalued Big Pharmaceutical Group Stocks Bought And Sold By Mega Funds
Seeking Alpha
Monday, January 2, 2012 - 10:58am
tags:
Abbott Laboratories, Allergan, AstraZeneca, Bristol-Myers Squibb, JNJ, GSK, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
Teva CEO Yanai to leave; ex-BMY executive succeeds
Marketwatch
Monday, January 2, 2012 - 10:54am
tags:
Teva Pharmaceuticals, Pharma CEOs, Shlomo Yanai
Takeda Actos Cancer Suits Combined in Louisiana Court, U.S. Panel Rules
Bloomberg
Saturday, December 31, 2011 - 1:00pm
tags:
Takeda, Actos, lawsuits
Elan Looks To Gain on Rumors of Possible Takeover Bid From Johnson & Johnson
BioMedReports
Saturday, December 31, 2011 - 12:56pm
tags:
Elan, JNJ
Valeant Bid Opens Eyes On ISTA Pharmaceuticals' Value
Seeking Alpha
Saturday, December 31, 2011 - 12:54pm
tags:
Valeant Pharmaceuticals, Ista
SuperGen has the Highest Future Earnings Growth in the Biotechnology Industry (SUPG, DUSA, GHDX)
Financial News Network
Saturday, December 31, 2011 - 12:51pm
tags:
Supergen
The Zacks Analyst Blog Highlights: Teva Pharmaceuticals, Mylan, Watson Pharma, Dr. Reddy's and Novartis
Sacramento Bee, CA
Saturday, December 31, 2011 - 12:48pm
tags:
Teva Pharmaceuticals, Mylan, Watson Pharmaceuticals, Dr Reddy's, Novartis, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.